GuideAI Health Launches Marketing and Investor Awareness Programs

GuideAI Health Corp. (Cboe CA: GDAI), a Canadian AI-powered health technology company, has taken a strategic step to bolster its market presence and boost investor awareness. The company announced it has engaged Upswitch Media Corp. and BTV-Business Television (BTV) to execute a coordinated marketing, communications, and investor-awareness program. This initiative aims to raise awareness of GuideAI's artificial intelligence (AI) platform for the detection and characterization of vascular disease among the news, investment, and healthcare communities.

Under the program, Upswitch Media will provide corporate marketing and investor-awareness services, including content creation and management, author sourcing, project management, and media distribution across various online communication channels. GuideAI Health has allocated an initial content creation and media distribution budget of a minimum of CAD $500,000 for this engagement. Additionally, BTV-Business Television will produce and broadcast a 30-second television spot scheduled to air approximately 50 times per week on BNN Bloomberg, for which the company will pay CAD $24,990.

This initiative follows GuideAI Health's recent public listing on Cboe Canada. The company began trading on Cboe Canada under the ticker symbol "GDAI" on June 29, 2026. The public listing was considered a significant milestone for GuideAI as it scales its platform and expands access to advanced diagnostic technology. The company also engaged DS Market Solutions Inc. as a market maker on July 2, 2026, to ensure a fair and efficient market for its shares.

GuideAI Health's core mission is to leverage AI for the early detection of vascular diseases and to support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease. By surfacing disease earlier, GuideAI aims to improve patient outcomes and assist hospitals and radiology groups in delivering more comprehensive vascular care. Joacim Wiklander, CEO of Cboe Canada, noted that GuideAI's work at the intersection of artificial intelligence and cardiovascular health represents the kind of innovative, high-growth company that Canadian public markets should be supporting.

The marketing and communications programs are crucial for GuideAI Health to expand its investor base and increase market penetration for its AI-powered healthcare solutions. Raj Shah, CEO of the company, emphasized that going public and broadening access to advanced diagnostic technology are key milestones for their mission. The increased visibility gained from these programs is expected to support the company's growth strategies, helping it achieve future financing and expansion goals. As GuideAI advances the development and deployment of its AI platform, it aims to broaden its reach across online, editorial, and broadcast channels.